vs
Side-by-side financial comparison of GoPro, Inc. (GPRO) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $201.7M, roughly 1.5× GoPro, Inc.). On growth, GoPro, Inc. posted the faster year-over-year revenue change (0.4% vs -6.4%). Over the past eight quarters, GoPro, Inc.'s revenue compounded faster (13.9% CAGR vs 4.2%).
GoPro, Inc. is an American technology company founded in 2002 by Nick Woodman. It manufactures action cameras and develops its own mobile apps and video-editing software. Founded as Woodman Labs, Inc, the company is based in San Mateo, California.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
GPRO vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $201.7M | $295.9M |
| Net Profit | — | $38.0M |
| Gross Margin | 31.8% | 64.6% |
| Operating Margin | -4.1% | 18.4% |
| Net Margin | — | 12.8% |
| Revenue YoY | 0.4% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | $-0.06 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $201.7M | $295.9M | ||
| Q3 25 | $162.9M | — | ||
| Q2 25 | $152.6M | $317.0M | ||
| Q1 25 | $134.3M | $316.2M | ||
| Q4 24 | $200.9M | $297.0M | ||
| Q3 24 | $258.9M | $289.5M | ||
| Q2 24 | $186.2M | $306.1M | ||
| Q1 24 | $155.5M | $303.4M |
| Q4 25 | — | $38.0M | ||
| Q3 25 | $-21.3M | — | ||
| Q2 25 | $-16.4M | $-17.7M | ||
| Q1 25 | $-46.7M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $-8.2M | $33.6M | ||
| Q2 24 | $-47.8M | $40.6M | ||
| Q1 24 | $-339.1M | $49.1M |
| Q4 25 | 31.8% | 64.6% | ||
| Q3 25 | 35.1% | — | ||
| Q2 25 | 35.8% | 62.7% | ||
| Q1 25 | 32.1% | 67.9% | ||
| Q4 24 | 34.7% | 65.3% | ||
| Q3 24 | 35.5% | 63.2% | ||
| Q2 24 | 30.5% | 66.4% | ||
| Q1 24 | 34.1% | 67.4% |
| Q4 25 | -4.1% | 18.4% | ||
| Q3 25 | -9.8% | — | ||
| Q2 25 | -9.2% | -7.5% | ||
| Q1 25 | -33.7% | 12.2% | ||
| Q4 24 | -19.5% | 16.0% | ||
| Q3 24 | -3.1% | 13.8% | ||
| Q2 24 | -25.0% | 15.0% | ||
| Q1 24 | -26.6% | 22.1% |
| Q4 25 | — | 12.8% | ||
| Q3 25 | -13.0% | — | ||
| Q2 25 | -10.8% | -5.6% | ||
| Q1 25 | -34.8% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | -3.2% | 11.6% | ||
| Q2 24 | -25.7% | 13.3% | ||
| Q1 24 | -218.1% | 16.2% |
| Q4 25 | $-0.06 | $0.24 | ||
| Q3 25 | $-0.13 | — | ||
| Q2 25 | $-0.10 | $-0.11 | ||
| Q1 25 | $-0.30 | $0.14 | ||
| Q4 24 | $-0.22 | $0.22 | ||
| Q3 24 | $-0.05 | $0.21 | ||
| Q2 24 | $-0.31 | $0.26 | ||
| Q1 24 | $-2.24 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.7M | $172.9M |
| Total DebtLower is stronger | $44.3M | $260.0M |
| Stockholders' EquityBook value | $76.5M | $2.0B |
| Total Assets | $428.0M | $2.5B |
| Debt / EquityLower = less leverage | 0.58× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.7M | $172.9M | ||
| Q3 25 | $152.8M | — | ||
| Q2 25 | $58.6M | $162.2M | ||
| Q1 25 | $69.6M | $140.7M | ||
| Q4 24 | $102.8M | $177.5M | ||
| Q3 24 | $130.2M | $187.5M | ||
| Q2 24 | $133.0M | $152.9M | ||
| Q1 24 | $133.7M | $145.3M |
| Q4 25 | $44.3M | $260.0M | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $0 | $300.0M | ||
| Q3 24 | $93.1M | $300.0M | ||
| Q2 24 | $92.9M | $319.0M | ||
| Q1 24 | $92.7M | $389.0M |
| Q4 25 | $76.5M | $2.0B | ||
| Q3 25 | $80.5M | — | ||
| Q2 25 | $97.9M | $1.9B | ||
| Q1 25 | $110.0M | $2.0B | ||
| Q4 24 | $151.7M | $2.1B | ||
| Q3 24 | $183.9M | $2.1B | ||
| Q2 24 | $184.7M | $2.1B | ||
| Q1 24 | $224.9M | $2.0B |
| Q4 25 | $428.0M | $2.5B | ||
| Q3 25 | $538.6M | — | ||
| Q2 25 | $439.0M | $2.6B | ||
| Q1 25 | $462.5M | $2.6B | ||
| Q4 24 | $543.7M | $2.7B | ||
| Q3 24 | $661.6M | $2.7B | ||
| Q2 24 | $556.8M | $2.7B | ||
| Q1 24 | $575.8M | $2.7B |
| Q4 25 | 0.58× | 0.13× | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 0.00× | 0.14× | ||
| Q3 24 | 0.51× | 0.14× | ||
| Q2 24 | 0.50× | 0.15× | ||
| Q1 24 | 0.41× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.6M | — |
| Free Cash FlowOCF − Capex | $15.0M | — |
| FCF MarginFCF / Revenue | 7.4% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-24.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | — | ||
| Q3 25 | $12.2M | — | ||
| Q2 25 | $8.8M | $98.2M | ||
| Q1 25 | $-57.2M | $41.1M | ||
| Q4 24 | $-25.1M | $84.3M | ||
| Q3 24 | $-2.2M | $63.9M | ||
| Q2 24 | $605.0K | $75.5M | ||
| Q1 24 | $-98.4M | $81.0M |
| Q4 25 | $15.0M | — | ||
| Q3 25 | $11.2M | — | ||
| Q2 25 | $8.3M | $93.3M | ||
| Q1 25 | $-58.5M | $31.0M | ||
| Q4 24 | $-25.5M | $77.5M | ||
| Q3 24 | $-4.2M | $54.7M | ||
| Q2 24 | $-111.0K | $57.5M | ||
| Q1 24 | $-99.4M | $64.5M |
| Q4 25 | 7.4% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 5.4% | 29.4% | ||
| Q1 25 | -43.5% | 9.8% | ||
| Q4 24 | -12.7% | 26.1% | ||
| Q3 24 | -1.6% | 18.9% | ||
| Q2 24 | -0.1% | 18.8% | ||
| Q1 24 | -63.9% | 21.3% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.3% | 1.5% | ||
| Q1 25 | 1.0% | 3.2% | ||
| Q4 24 | 0.2% | 2.3% | ||
| Q3 24 | 0.8% | 3.2% | ||
| Q2 24 | 0.4% | 5.9% | ||
| Q1 24 | 0.6% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GPRO
| Subscription And Services | $106.3M | 53% |
| Other | $95.4M | 47% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
